This report contains market size and forecasts of Cancer Cell Biopsy Service in Global, including the following market information:
Global Cancer Cell Biopsy Service Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cancer Cell Biopsy Service market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Incisional Biopsy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Cell Biopsy Service include ANGLE, Fluxion Biosciences, Inivata, GRAIL, Guardant Health, Caris, Liquid Biopsy Labs, DermTech and QIAGEN, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Cancer Cell Biopsy Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Cell Biopsy Service Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Cell Biopsy Service Market Segment Percentages, by Type, 2021 (%)
Incisional Biopsy
Needle Biopsy
Global Cancer Cell Biopsy Service Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Cell Biopsy Service Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Cancer Cell Biopsy Service Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Cell Biopsy Service Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Cell Biopsy Service revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cancer Cell Biopsy Service revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ANGLE
Fluxion Biosciences
Inivata
GRAIL
Guardant Health
Caris
Liquid Biopsy Labs
DermTech
QIAGEN
Lucence
Biocept
CELLSEARCH
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Cancer Cell Biopsy Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Cell Biopsy Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Cell Biopsy Service Overall Market Size
2.1 Global Cancer Cell Biopsy Service Market Size: 2021 VS 2028
2.2 Global Cancer Cell Biopsy Service Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Cell Biopsy Service Players in Global Market
3.2 Top Global Cancer Cell Biopsy Service Companies Ranked by Revenue
3.3 Global Cancer Cell Biopsy Service Revenue by Companies
3.4 Top 3 and Top 5 Cancer Cell Biopsy Service Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Cell Biopsy Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Cell Biopsy Service Players in Global Market
3.6.1 List of Global Tier 1 Cancer Cell Biopsy Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Cell Biopsy Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cancer Cell Biopsy Service Market Size Markets, 2021 & 2028
4.1.2 Incisional Biopsy
4.1.3 Needle Biopsy
4.2 By Type - Global Cancer Cell Biopsy Service Revenue & Forecasts
4.2.1 By Type - Global Cancer Cell Biopsy Service Revenue, 2017-2022
4.2.2 By Type - Global Cancer Cell Biopsy Service Revenue, 2023-2028
4.2.3 By Type - Global Cancer Cell Biopsy Service Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Cell Biopsy Service Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Cancer Cell Biopsy Service Revenue & Forecasts
5.2.1 By Application - Global Cancer Cell Biopsy Service Revenue, 2017-2022
5.2.2 By Application - Global Cancer Cell Biopsy Service Revenue, 2023-2028
5.2.3 By Application - Global Cancer Cell Biopsy Service Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Cancer Cell Biopsy Service Market Size, 2021 & 2028
6.2 By Region - Global Cancer Cell Biopsy Service Revenue & Forecasts
6.2.1 By Region - Global Cancer Cell Biopsy Service Revenue, 2017-2022
6.2.2 By Region - Global Cancer Cell Biopsy Service Revenue, 2023-2028
6.2.3 By Region - Global Cancer Cell Biopsy Service Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cancer Cell Biopsy Service Revenue, 2017-2028
6.3.2 US Cancer Cell Biopsy Service Market Size, 2017-2028
6.3.3 Canada Cancer Cell Biopsy Service Market Size, 2017-2028
6.3.4 Mexico Cancer Cell Biopsy Service Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cancer Cell Biopsy Service Revenue, 2017-2028
6.4.2 Germany Cancer Cell Biopsy Service Market Size, 2017-2028
6.4.3 France Cancer Cell Biopsy Service Market Size, 2017-2028
6.4.4 U.K. Cancer Cell Biopsy Service Market Size, 2017-2028
6.4.5 Italy Cancer Cell Biopsy Service Market Size, 2017-2028
6.4.6 Russia Cancer Cell Biopsy Service Market Size, 2017-2028
6.4.7 Nordic Countries Cancer Cell Biopsy Service Market Size, 2017-2028
6.4.8 Benelux Cancer Cell Biopsy Service Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cancer Cell Biopsy Service Revenue, 2017-2028
6.5.2 China Cancer Cell Biopsy Service Market Size, 2017-2028
6.5.3 Japan Cancer Cell Biopsy Service Market Size, 2017-2028
6.5.4 South Korea Cancer Cell Biopsy Service Market Size, 2017-2028
6.5.5 Southeast Asia Cancer Cell Biopsy Service Market Size, 2017-2028
6.5.6 India Cancer Cell Biopsy Service Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cancer Cell Biopsy Service Revenue, 2017-2028
6.6.2 Brazil Cancer Cell Biopsy Service Market Size, 2017-2028
6.6.3 Argentina Cancer Cell Biopsy Service Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Cell Biopsy Service Revenue, 2017-2028
6.7.2 Turkey Cancer Cell Biopsy Service Market Size, 2017-2028
6.7.3 Israel Cancer Cell Biopsy Service Market Size, 2017-2028
6.7.4 Saudi Arabia Cancer Cell Biopsy Service Market Size, 2017-2028
6.7.5 UAE Cancer Cell Biopsy Service Market Size, 2017-2028
7 Players Profiles
7.1 ANGLE
7.1.1 ANGLE Corporate Summary
7.1.2 ANGLE Business Overview
7.1.3 ANGLE Cancer Cell Biopsy Service Major Product Offerings
7.1.4 ANGLE Cancer Cell Biopsy Service Revenue in Global Market (2017-2022)
7.1.5 ANGLE Key News
7.2 Fluxion Biosciences
7.2.1 Fluxion Biosciences Corporate Summary
7.2.2 Fluxion Biosciences Business Overview
7.2.3 Fluxion Biosciences Cancer Cell Biopsy Service Major Product Offerings
7.2.4 Fluxion Biosciences Cancer Cell Biopsy Service Revenue in Global Market (2017-2022)
7.2.5 Fluxion Biosciences Key News
7.3 Inivata
7.3.1 Inivata Corporate Summary
7.3.2 Inivata Business Overview
7.3.3 Inivata Cancer Cell Biopsy Service Major Product Offerings
7.3.4 Inivata Cancer Cell Biopsy Service Revenue in Global Market (2017-2022)
7.3.5 Inivata Key News
7.4 GRAIL
7.4.1 GRAIL Corporate Summary
7.4.2 GRAIL Business Overview
7.4.3 GRAIL Cancer Cell Biopsy Service Major Product Offerings
7.4.4 GRAIL Cancer Cell Biopsy Service Revenue in Global Market (2017-2022)
7.4.5 GRAIL Key News
7.5 Guardant Health
7.5.1 Guardant Health Corporate Summary
7.5.2 Guardant Health Business Overview
7.5.3 Guardant Health Cancer Cell Biopsy Service Major Product Offerings
7.5.4 Guardant Health Cancer Cell Biopsy Service Revenue in Global Market (2017-2022)
7.5.5 Guardant Health Key News
7.6 Caris
7.6.1 Caris Corporate Summary
7.6.2 Caris Business Overview
7.6.3 Caris Cancer Cell Biopsy Service Major Product Offerings
7.6.4 Caris Cancer Cell Biopsy Service Revenue in Global Market (2017-2022)
7.6.5 Caris Key News
7.7 Liquid Biopsy Labs
7.7.1 Liquid Biopsy Labs Corporate Summary
7.7.2 Liquid Biopsy Labs Business Overview
7.7.3 Liquid Biopsy Labs Cancer Cell Biopsy Service Major Product Offerings
7.7.4 Liquid Biopsy Labs Cancer Cell Biopsy Service Revenue in Global Market (2017-2022)
7.7.5 Liquid Biopsy Labs Key News
7.8 DermTech
7.8.1 DermTech Corporate Summary
7.8.2 DermTech Business Overview
7.8.3 DermTech Cancer Cell Biopsy Service Major Product Offerings
7.8.4 DermTech Cancer Cell Biopsy Service Revenue in Global Market (2017-2022)
7.8.5 DermTech Key News
7.9 QIAGEN
7.9.1 QIAGEN Corporate Summary
7.9.2 QIAGEN Business Overview
7.9.3 QIAGEN Cancer Cell Biopsy Service Major Product Offerings
7.9.4 QIAGEN Cancer Cell Biopsy Service Revenue in Global Market (2017-2022)
7.9.5 QIAGEN Key News
7.10 Lucence
7.10.1 Lucence Corporate Summary
7.10.2 Lucence Business Overview
7.10.3 Lucence Cancer Cell Biopsy Service Major Product Offerings
7.10.4 Lucence Cancer Cell Biopsy Service Revenue in Global Market (2017-2022)
7.10.5 Lucence Key News
7.11 Biocept
7.11.1 Biocept Corporate Summary
7.11.2 Biocept Business Overview
7.11.3 Biocept Cancer Cell Biopsy Service Major Product Offerings
7.11.4 Biocept Cancer Cell Biopsy Service Revenue in Global Market (2017-2022)
7.11.5 Biocept Key News
7.12 CELLSEARCH
7.12.1 CELLSEARCH Corporate Summary
7.12.2 CELLSEARCH Business Overview
7.12.3 CELLSEARCH Cancer Cell Biopsy Service Major Product Offerings
7.12.4 CELLSEARCH Cancer Cell Biopsy Service Revenue in Global Market (2017-2022)
7.12.5 CELLSEARCH Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Cancer Cell Biopsy Service Market Opportunities & Trends in Global Market
Table 2. Cancer Cell Biopsy Service Market Drivers in Global Market
Table 3. Cancer Cell Biopsy Service Market Restraints in Global Market
Table 4. Key Players of Cancer Cell Biopsy Service in Global Market
Table 5. Top Cancer Cell Biopsy Service Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Cell Biopsy Service Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Cell Biopsy Service Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Cell Biopsy Service Product Type
Table 9. List of Global Tier 1 Cancer Cell Biopsy Service Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Cell Biopsy Service Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Cancer Cell Biopsy Service Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Cell Biopsy Service Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Cell Biopsy Service Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Cancer Cell Biopsy Service Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Cell Biopsy Service Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Cell Biopsy Service Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Cancer Cell Biopsy Service Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Cell Biopsy Service Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Cell Biopsy Service Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Cell Biopsy Service Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Cell Biopsy Service Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Cell Biopsy Service Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Cell Biopsy Service Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Cell Biopsy Service Revenue, (US$, Mn), 2023-2028
Table 30. ANGLE Corporate Summary
Table 31. ANGLE Cancer Cell Biopsy Service Product Offerings
Table 32. ANGLE Cancer Cell Biopsy Service Revenue (US$, Mn), (2017-2022)
Table 33. Fluxion Biosciences Corporate Summary
Table 34. Fluxion Biosciences Cancer Cell Biopsy Service Product Offerings
Table 35. Fluxion Biosciences Cancer Cell Biopsy Service Revenue (US$, Mn), (2017-2022)
Table 36. Inivata Corporate Summary
Table 37. Inivata Cancer Cell Biopsy Service Product Offerings
Table 38. Inivata Cancer Cell Biopsy Service Revenue (US$, Mn), (2017-2022)
Table 39. GRAIL Corporate Summary
Table 40. GRAIL Cancer Cell Biopsy Service Product Offerings
Table 41. GRAIL Cancer Cell Biopsy Service Revenue (US$, Mn), (2017-2022)
Table 42. Guardant Health Corporate Summary
Table 43. Guardant Health Cancer Cell Biopsy Service Product Offerings
Table 44. Guardant Health Cancer Cell Biopsy Service Revenue (US$, Mn), (2017-2022)
Table 45. Caris Corporate Summary
Table 46. Caris Cancer Cell Biopsy Service Product Offerings
Table 47. Caris Cancer Cell Biopsy Service Revenue (US$, Mn), (2017-2022)
Table 48. Liquid Biopsy Labs Corporate Summary
Table 49. Liquid Biopsy Labs Cancer Cell Biopsy Service Product Offerings
Table 50. Liquid Biopsy Labs Cancer Cell Biopsy Service Revenue (US$, Mn), (2017-2022)
Table 51. DermTech Corporate Summary
Table 52. DermTech Cancer Cell Biopsy Service Product Offerings
Table 53. DermTech Cancer Cell Biopsy Service Revenue (US$, Mn), (2017-2022)
Table 54. QIAGEN Corporate Summary
Table 55. QIAGEN Cancer Cell Biopsy Service Product Offerings
Table 56. QIAGEN Cancer Cell Biopsy Service Revenue (US$, Mn), (2017-2022)
Table 57. Lucence Corporate Summary
Table 58. Lucence Cancer Cell Biopsy Service Product Offerings
Table 59. Lucence Cancer Cell Biopsy Service Revenue (US$, Mn), (2017-2022)
Table 60. Biocept Corporate Summary
Table 61. Biocept Cancer Cell Biopsy Service Product Offerings
Table 62. Biocept Cancer Cell Biopsy Service Revenue (US$, Mn), (2017-2022)
Table 63. CELLSEARCH Corporate Summary
Table 64. CELLSEARCH Cancer Cell Biopsy Service Product Offerings
Table 65. CELLSEARCH Cancer Cell Biopsy Service Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Cancer Cell Biopsy Service Segment by Type in 2021
Figure 2. Cancer Cell Biopsy Service Segment by Application in 2021
Figure 3. Global Cancer Cell Biopsy Service Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Cell Biopsy Service Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Cell Biopsy Service Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Cell Biopsy Service Revenue in 2021
Figure 8. By Type - Global Cancer Cell Biopsy Service Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Cell Biopsy Service Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Cell Biopsy Service Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Cell Biopsy Service Revenue Market Share, 2017-2028
Figure 12. US Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Cell Biopsy Service Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Cell Biopsy Service Revenue Market Share, 2017-2028
Figure 24. China Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Cell Biopsy Service Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Cell Biopsy Service Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Cell Biopsy Service Revenue, (US$, Mn), 2017-2028
Figure 37. ANGLE Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Fluxion Biosciences Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Inivata Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GRAIL Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Guardant Health Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Caris Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Liquid Biopsy Labs Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. DermTech Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. QIAGEN Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Lucence Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Biocept Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. CELLSEARCH Cancer Cell Biopsy Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)